Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy

Glioblastoma (GBM) is the most common and devastating malignant brain tumor in adults. The mortality rate is very high despite different treatments. New therapeutic targets are therefore highly needed. Cell-surface proteins represent attractive targets due to their accessibility, their involvement i...

Full description

Bibliographic Details
Main Authors: Mélanie Rose, Tristan Cardon, Soulaimane Aboulouard, Nawale Hajjaji, Firas Kobeissy, Marie Duhamel, Isabelle Fournier, Michel Salzet
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
surfaceome proteomic
glioblastoma
immune therapy
surface proteins
mutated proteins
drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.746168/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.746168/full

Similar Items